Arterys Cardio DL vs AVIEW LCS
AI Verdict
Choose Arterys Cardio DL if…
Choose Arterys Cardio DL if your primary need is rapid, accurate, and automated analysis of cardiac MRI studies. This tool is ideal for cardiologists and radiologists seeking to streamline ventricle segmentation, quantify blood flow with 4D Flow, and perform quantitative delayed enhancement analysis to enhance diagnostic confidence in cardiac function.
View Arterys Cardio DL →Choose AVIEW LCS if…
Choose AVIEW LCS if you require an integrated AI solution for comprehensive cardiopulmonary assessment from low-dose CT scans. This platform is best suited for practices focused on automated lung nodule detection, emphysema quantification, and coronary artery calcification scoring, providing a streamlined workflow for multiple critical diagnoses.
View AVIEW LCS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Arterys Cardio DL | AVIEW LCS |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27] | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Arterys Cardio DLTool A explicitly highlights 'editable automated contours,' which provides clinicians with crucial control and the ability to fine-tune AI outputs, enhancing trust and practical usability in a clinical workflow. Its cloud-based nature also ensures easy accessibility and rapid processing. While Tool B offers comprehensive automation and integration, the explicit emphasis on editable outputs in Tool A gives it a slight edge in user control.
Clinical Value
AVIEW LCSTool B offers a broader clinical utility by assessing multiple critical conditions (lung cancer, COPD, and coronary artery calcification) from a single low-dose CT scan, providing a more comprehensive cardiopulmonary assessment. This integrated approach can significantly enhance screening programs and provide a holistic view of patient health. Tool A, while highly effective in its specialized cardiac MRI domain, has a narrower focus.
Pricing & Value
TieBoth tools require direct contact for pricing information, making a direct comparison of their cost or value proposition impossible based on the provided data. Without transparent pricing, it is difficult to determine which offers better financial value. Therefore, this dimension is a tie.
Enterprise Readiness
AVIEW LCSTool B demonstrates superior enterprise readiness due to its highly flexible deployment options, including cloud, hybrid, local hardware, and virtualized solutions, catering to diverse IT infrastructures and security requirements. Its explicit integration with PACS/RIS and third-party platforms further ensures seamless adoption into existing clinical workflows. Tool A is limited to cloud-based deployment.
Innovation
Arterys Cardio DLTool A claims to be 'the world's first internet platform for medical imaging,' indicating a pioneering role in bringing cloud-based AI to medical diagnostics, which was a significant innovation at its inception. While Tool B's integrated multi-disease assessment from a single scan is highly innovative for comprehensive screening, Tool A's foundational platform innovation holds a broader historical significance in the field.
Support & Docs
TieBoth companies, Arterys and Coreline Soft, appear to offer standard customer support channels, including technical assistance and potentially training resources, as indicated by their corporate websites. However, the provided structured facts and general web searches do not offer sufficient granular detail on the quality, comprehensiveness of documentation, or responsiveness of support to definitively distinguish between the two.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Arterys Cardio DL | AVIEW LCS |
|---|---|---|
| Name | Arterys Cardio DL | AVIEW LCS |
| Primary Focus | Automated, editable ventricle segmentations for cardiac MRI analysis | AI-powered solution for the detection and analysis of lung nodules, lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan |
| Company | ARTERYS | Coreline Soft Co. |
| Specific Analysis Type 1 | Automated ventricle segmentations for cardiac MRI | Automated lung nodule detection and analysis |
| Specific Analysis Type 2 | 4D Flow post-processing for blood flow visualization and quantification | Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass) |
| Specific Analysis Type 3 | Quantitative Delayed Enhancement analysis | Emphysema quantification (LAA index) |
Videos
Demos, reviews, and walkthroughs featuring Arterys Cardio DL and AVIEW LCS.